Fatty Liver News and Research

Latest Fatty Liver News and Research

What is the association between fast-food intake and liver steatosis?

Researchers quantified the adverse effects of fast-food intake on liver steatosis in new research.

18 Jan 2023

American Academy of Pediatrics releases the first clinical practice guideline for evaluating and treating childhood obesity

A recent news article published by the American Academy of Pediatrics (AAP) discussed the first clinical practice guideline released by the AAP to effectively and safely evaluate and treat pediatric obesity in children and adolescents.

13 Jan 2023

Effectiveness of slow eating intervention tested in overweight and obese women

A recent Eating Behaviors study has aimed to develop and test the effectiveness of a 5-week slow-eating intervention in obese women.

11 Jan 2023

Eating fast food associated with nonalcoholic fatty liver disease

The new year has begun, and with it, resolutions for change. A study from Keck Medicine of USC published today in Clinical Gastroenterology and Hepatology gives people extra motivation to reduce fast-food consumption.

10 Jan 2023

Hair follicle transplants can rejuvenate scars, study finds

In a new study involving three volunteers, skin scars began to behave more like uninjured skin after they were treated with hair follicle transplants.

6 Jan 2023

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other cardiorenal and metabolic diseases. A detailed report on recommended strategies has been published in the Journal of Diabetes and its Complications.

4 Jan 2023

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Using the latest technologies - including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells - researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

4 Jan 2023

The metabolic links between diet-induced changes in the gut and NASH

Scientists reviewed the metabolic association between diet-induced alterations in the gut and NASH

4 Jan 2023

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.

27 Dec 2022

Study links NAFLD with brain deterioration and identifies a potential therapeutic target

People with liver disease caused by eating too much sugar and fat could be at increased risk of developing serious neurological conditions like depression or dementia.

22 Dec 2022

Common type 2 diabetes drug requires the presence of GDF15 cytokine to present antidiabetic effects

Metformin, the most prescribed drug for treating diabetes mellitus, known as type 2 diabetes, requires the presence of the growth differentiation factor 15 (GDF15) —a protein whose expression increases in response to cellular stress— to present its antidiabetic effects.

16 Dec 2022

Revised guidelines for diabetes care

A recent Diabetes Care journal paper summarized the latest recommendations offered to people with diabetes to improve their health and well-being.

15 Dec 2022

Researchers unravel the molecular mechanisms of steatosis-to-NASH progression

The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be > 25% and will continue to rise.

15 Dec 2022

Study shows how dietary saturated/trans fats promote liver tumorigenesis

Fatty foods harm our health. Prior research has established a link between the consumption of dietary fats and non-alcoholic fatty liver disease, which subsequently leads to inflammation and tumor formation in the liver.

7 Dec 2022

Gut microbial flavonoid catabolite reverses fatty liver disease in mice

Researchers report that a gut microbial catabolite could reduce the cardiometabolic disease burden in mice.

29 Nov 2022

MIT researchers develop new technique for genome-wide studies of the liver

The liver’s ability to regenerate itself is legendary. Even if more than 70 percent of the organ is removed, the remaining tissue can regrow an entire new liver.

21 Nov 2022

Honey improves key measures of health, including blood sugar and cholesterol levels

Researchers look to better understand the impact of honey on mitigating certain cardiometabolic risk factors.

20 Nov 2022

New AI blood testing technology detects more than 80% of liver cancers

A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.

20 Nov 2022

Novel drug lowers triglycerides, does not reduce cardiovascular events

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.

6 Nov 2022

Environmental toxicants contribute to obesity and metabolic disease

In a recent study published in the Current Opinion in Pharmacology journal, researchers assessed the impact of environmental toxicants and brown adipose tissue (BAT) on obesity and metabolic disorders.

4 Nov 2022

Fatty Liver News and Research

Latest Fatty Liver News and Research

What is the association between fast-food intake and liver steatosis?

American Academy of Pediatrics releases the first clinical practice guideline for evaluating and treating childhood obesity

Effectiveness of slow eating intervention tested in overweight and obese women

Eating fast food associated with nonalcoholic fatty liver disease

Hair follicle transplants can rejuvenate scars, study finds

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

The metabolic links between diet-induced changes in the gut and NASH

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

Study links NAFLD with brain deterioration and identifies a potential therapeutic target

Common type 2 diabetes drug requires the presence of GDF15 cytokine to present antidiabetic effects

Revised guidelines for diabetes care

Researchers unravel the molecular mechanisms of steatosis-to-NASH progression

Study shows how dietary saturated/trans fats promote liver tumorigenesis

Gut microbial flavonoid catabolite reverses fatty liver disease in mice

MIT researchers develop new technique for genome-wide studies of the liver

Honey improves key measures of health, including blood sugar and cholesterol levels

New AI blood testing technology detects more than 80% of liver cancers

Novel drug lowers triglycerides, does not reduce cardiovascular events

Environmental toxicants contribute to obesity and metabolic disease

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Fatty Liver News and Research

Latest Fatty Liver News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in